Search Results - "Helton, W Scott"

Refine Results
  1. 1

    An analytical review of vasculobiliary injury in laparoscopic and open cholecystectomy by Strasberg, Steven M, Helton, W. Scott

    Published in HPB (Oxford, England) (01-01-2011)
    “…Abstract Objectives Biliary injuries are frequently accompanied by vascular injuries, which may worsen the bile duct injury and cause liver ischemia. We…”
    Get full text
    Journal Article
  2. 2

    Sustained Carbohydrate Antigen 19‐9 Response to Neoadjuvant Chemotherapy in Borderline Resectable Pancreatic Cancer Predicts Progression and Survival by Rose, J. Bart, Edwards, Alicia M., Rocha, Flavio G., Clark, Carolyn, Alseidi, Adnan A., Biehl, Thomas R., Lin, Bruce S., Picozzi, Vincent J., Helton, W. Scott

    Published in The oncologist (Dayton, Ohio) (01-10-2020)
    “…Background As neoadjuvant therapy of borderline resectable pancreatic cancer (BRPC) is becoming more widely used, better indicators of progression are needed…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature by Garrean, Sean, M.D, Hering, Justin, M.D, Saied, Abdul, M.D, Helton, W. Scott, M.D, Espat, N. Joseph, M.D., M.S

    Published in The American journal of surgery (01-04-2008)
    “…Abstract Background Surgical resection is the treatment of choice for hepatic tumors; however, for various reasons, the vast majority of patients are not…”
    Get full text
    Journal Article
  6. 6

    Interferon-based Adjuvant Chemoradiation for Resected Pancreatic Head Cancer: Long-term Follow-up of the Virginia Mason Protocol by Rocha, Flavio G, Hashimoto, Yashushi, Traverso, L William, Dorer, Russell, Kozarek, Richard, Helton, W Scott, Picozzi, Vincent J

    Published in Annals of surgery (01-02-2016)
    “…OBJECTIVE:To report the long-term impact of adjuvant interferon-based chemoradiation therapy (IFN-CRT) after pancreaticoduodenectomy (PD) for pancreatic…”
    Get full text
    Journal Article
  7. 7

    Pretreatment assessment of hepatocellular carcinoma: expert consensus statement by Vauthey, Jean-Nicolas, Dixon, Elijah, Abdalla, Eddie K., Helton, W. Scott, Pawlik, Timothy M., Taouli, Bachir, Brouquet, Antoine, Adams, Reid B.

    Published in HPB (Oxford, England) (01-06-2010)
    “…Staging of hepatocellular carcinoma (HCC) is complex and relies on multiple factors including tumor extent and hepatic function. No single staging system is…”
    Get full text
    Journal Article Conference Proceeding
  8. 8

    The Role of Biliary Carcinoembryonic Antigen-Related Cellular Adhesion Molecule 6 (CEACAM6) as a Biomarker in Cholangiocarcinoma by Rose, J Bart, Correa-Gallego, Camilo, Li, Yu, Nelson, James, Alseidi, Adnan, Helton, W Scott, Allen, Peter J, D'Angelica, Michael I, DeMatteo, Ronald P, Fong, Yuman, Kingham, T Peter, Kowdley, Kris V, Jarnagin, William R, Rocha, Flavio G

    Published in PloS one (14-03-2016)
    “…The aim of the present study is to determine if CEACAM6 can be detected in the bile of patients with biliary cancer and can serve as a diagnostic biomarker for…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    Abdominal wall reconstruction using biological tissue grafts: present status and future opportunities by Bellows, Charles F, Alder, Adam, Helton, W Scott

    Published in Expert review of medical devices (01-09-2006)
    “…Surgeons often encounter the challenge of treating acquired abdominal wall defects following abdominal surgery. The current standard of practice is to repair…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Enterolith Causing Afferent Loop Obstruction: A Case Report and Literature Review by Lee, Michael C., Bui, James T., Knuttinen, M-Grace, Gaba, Ron C., Scott Helton, W., Owens, Charles A.

    “…Enterolith formation is a rare cause of afferent limb obstruction following Billroth II gastrectomy and Roux-en-Y hepaticojejunostomy surgery. A case of…”
    Get full text
    Journal Article
  15. 15

    A primer on transarterial, chemical, and thermal ablative therapies for hepatic tumors by Garrean, Sean, M.D, Hering, Justin, M.D, Helton, W. Scott, M.D, Espat, N. Joseph, M.D

    Published in The American journal of surgery (01-07-2007)
    “…Abstract Background Surgical resection is the only potentially curative approach for patients with primary and metastatic liver tumors. Unfortunately, most…”
    Get full text
    Journal Article
  16. 16

    Hepatic and Splenic Hydatidosis Managed with Percutaneous Aspiration, Injection, and Reaspiration (PAIR) of the Hepatic Cyst and Laparoscopic Splenectomy by Marco Fisichella, P., Donaldson, Kristen, Scott Helton, W.

    Published in Journal of gastrointestinal surgery (01-09-2008)
    “…The treatment of hydatidosis traditionally consisted of surgery with a perioperative course of anthelmintic medications. However, percutaneous aspiration,…”
    Get full text
    Journal Article
  17. 17

    Evaluation of a bipolar radiofrequency device for laparoscopic hepatic resection: technique and clinical experience in 18 patients by Somasundar, Ponnandai, Boutros, Cherif, Helton, W. Scott, Espat, N. Joseph

    Published in HPB (Oxford, England) (01-03-2009)
    “…The increased frequency of laparoscopic hepatic resection as a principal or adjunct component of patient care has driven the need for and development of…”
    Get full text
    Journal Article
  18. 18

    G2/M Cell-Cycle Arrest and Apoptosis by n-3 Fatty Acids in a Pancreatic Cancer Model by Dekoj, Thomas, MD, Lee, Sang, MD, Desai, Sagun, MD, Trevino, Jose, MD, Babcock, Tricia A., MS, Helton, W. Scott, MD, FACS, Espat, N. Joseph, MD, MS, FACS

    Published in The Journal of surgical research (01-05-2007)
    “…Background n-3 fatty acids (n-3FA) have anti-inflammatory and anti-proliferative effects including modulation of pro-inflammatory cascade mediators and…”
    Get full text
    Journal Article
  19. 19
  20. 20